VLA-4/CD49d downregulated on primed T lymphocytes during interferon-β therapy in multiple sclerosis
- 1 November 2000
- journal article
- Published by Elsevier BV in Journal of Neuroimmunology
- Vol. 111 (1-2), 186-194
- https://doi.org/10.1016/s0165-5728(00)00362-3
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Phenotypic and Functional Separation of Memory and Effector Human CD8+ T CellsThe Journal of Experimental Medicine, 1997
- Microglial production of TNF-alpha is induced by activated T lymphocytes. Involvement of VLA-4 and inhibition by interferonbeta-1b.JCI Insight, 1997
- Magnetic resonance imaging changes with recombinant human interferon-beta-1a: a short term study in relapsing-remitting multiple sclerosis.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosisAnnals of Neurology, 1996
- The effect of interferon‐β on blood—brain barrier disruptions demonstrated by constrast‐enhanced magnetic resonance imaging in relapsing—remitting multiple sclerosisAnnals of Neurology, 1995
- The adhesion molecule and cytokine profile of multiple sclerosis lesionsAnnals of Neurology, 1995
- Regulatory mechanisms in leukocyte adhesion: flexible receptors for sophisticated travelersImmunology Today, 1992
- Lymphocyte interactions with endothelial cellsImmunology Today, 1992
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992
- Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrinNature, 1992